Completed PHASE4 INTERVENTIONAL 2-arm NCT02455921

Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in Children

Comparative Effect of Neuromuscular Blockade Reversal Agent on Extubation Conditions, Postoperative Cognitive Function and Behaviour of School-aged Children Undergoing Ear Note Throat (ENT) Surgery

Sponsor: Attikon Hospital

Conditions Anesthesia; Functional

Interventions Sugammadex neostigmine - atropine

Updated 8 times since 2017 Last updated: Oct 23, 2018 Started: Jun 30, 2015 Primary completion: Mar 31, 2018 Completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Anesthesia; Functional, this trial is completed. The trial is conducted by Attikon Hospital and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2018 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jul 2018 — Nov 2018 [monthly]

Recruiting PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jul 2018 [monthly]

Recruiting PHASE4
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Enrolling By Invitation → Recruiting
Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation PHASE4

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Attikon Hospital

Data source: Attikon Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, Greece